Arca
Skip to content
Tools
Tools

Label Changes: Cefazolin Sodium Solution (cefazolin sodium)

A drug's label (its prescribing information) is revised many times after approval: new warnings, new uses, new doses. DailyMed keeps every version. Pick a drug to see them all and what changed between any two.

Every version of the Cefazolin Sodium Solution label DailyMed has published, from B. Braun Medical Inc., and what changed between any two of them, section by section. Current label on DailyMed.

  • Versions on DailyMed: 12
  • Sections changed, version 28 to 31: 2

What changed from version 28 to version 31

Nov 18, 2024 to Apr 10, 2025, as published on DailyMed. Added text is underlined in green, removed text struck through in red.
  1. PRINCIPAL DISPLAY PANEL - 1g CefazolinChanged · 24 words added, 22 removed
  2. PRINCIPAL DISPLAY PANEL - 2g CefazolinChanged · 17 words added, 14 removed

PRINCIPAL DISPLAY PANEL - 1g Cefazolin

Changed24 words added, 22 removed
4 unchanged lines
DUPLEX® CONTAINER
Use only after mixing contents of both chambers. For IV Use Only Iso-osmotic Single -Dose Sterile/Nonpyrogenic * Contains 1.048 g of Cefazolin Sodium USP equivalent to 1 g cefazolin.
Reconstitution: Hold container with set port in a downward direction and fold the diluent chamber just below the solution meniscus. To activate seal, squeeze folded diluent chamber until seal between diluent and drug chamber opens, releasing diluent into drug chamber. Agitate the reconstituted solution until the drug powder is completely dissolved. Fold the container a second time and squeeze until seal between drug chamber and set port opens.
After reconstitution each 50 mL single -dose unit contains: Cefazolin for Injection USP (1 g cefazolin, equivalent to 1.048 g of cefazolin sodium) with approx. 2.0 g (4.0% w/v) Hydrous Dextrose USP in Water for Injection USP. Sodium content is 48 mg/g of cefazolin sodium. Approximate osmolality: 290 mOsmol/kg
Prior to Reconstitution: Store at 20-25°C (68-77°F). Excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Use only if container and seals are intact. Do not peel foil strip until ready for use. After foil strip removal, product must be used within 7 days, but not beyond the labeled expiration date. Protect from light after removal of foil strip.
After Reconstitution: Use only if prepared solution is clear and free from particulate matter. Use within 24 hours if stored at room temperature or within 7 days if stored under refrigeration. Do not use in a series connection. Do not introduce additives into this container. Prior to administration check for minute leaks by squeezing container firmly. If leaks are found, discard container and solution as sterility may be impaired. Do not freeze. Not made with natural rubber latex, PVCDiscard orunused DEHPportion.
Not made with natural rubber latex, PVC or DEHP.
Rx only
1 unchanged line
Prepared in USA. API from USA and Italy.
LD-201-79 Y37-002-541610
EXP LOT
2 unchanged lines

PRINCIPAL DISPLAY PANEL - 2g Cefazolin

Changed17 words added, 14 removed
4 unchanged lines
DUPLEX® CONTAINER
Use only after mixing contents of both chambers. For IV Use Only Iso-osmotic Single -Dose Sterile/Nonpyrogenic * Contains 2.096 g of Cefazolin Sodium USP equivalent to 2 g cefazolin.
Reconstitution: Hold container with set port in a downward direction and fold the diluent chamber just below the solution meniscus. To activate seal, squeeze folded diluent chamber until seal between diluent and drug chamber opens, releasing diluent into drug chamber. Agitate the reconstituted solution until the drug powder is completely dissolved. Fold the container a second time and squeeze until seal between drug chamber and set port opens.
After reconstitution each 50 mL single -dose unit contains: Cefazolin for Injection USP (2 g cefazolin, equivalent to 2.096 g of cefazolin sodium) with approx. 1.5 g (3.0% w/v) Hydrous Dextrose USP in Water for Injection USP. Sodium content is 48 mg/g of cefazolin sodium. Approximate osmolality: 290 mOsmol/kg
Prior to Reconstitution: Store at 20-25°C (68-77°F). Excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Use only if container and seals are intact. Do not peel foil strip until ready for use. After foil strip removal, product must be used within 7 days, but not beyond the labeled expiration date. Protect from light after removal of foil strip.
After Reconstitution: Use only if prepared solution is clear and free from particulate matter. Use within 24 hours if stored at room temperature or within 7 days if stored under refrigeration. Do not use in a series connection. Do not introduce additives into this container. Prior to administration check for minute leaks by squeezing container firmly. If leaks are found, discard container and solution as sterility may be impaired. Do not freeze. Discard unused portion. Not made with natural rubber latex, PVC or DEHP.
Rx only
Rx only B. Braun Medical Inc. Bethlehem, PA 18018-3524
Prepared in USA. API from USA and Italy.
LD-200-46 Y37-002-542611
EXP LOT
2 unchanged lines

Unchanged: Recent major changes, Indications and usage, Dosage and administration, Dosage forms and strengths, Contraindications, Warnings and precautions, Adverse reactions, Drug interactions, Use in specific populations, Overdosage, Description, Clinical pharmacology, Nonclinical toxicology, References, How supplied, Patient counseling information, Untitled section, PRINCIPAL DISPLAY PANEL - 3g Cefazolin.

Every version

12 versions of set 17f8f038-c204-4dab-80d7-6f7ac41ddbec, newest first.
VersionPublished on DailyMedCompareSPL file
31Apr 10, 2025Shown belowDownload .zip
28Nov 18, 2024With version 22Download .zip
22Jan 10, 2024With version 20Download .zip
20Sep 13, 2021With version 18Download .zip
18Dec 8, 2020With version 14Download .zip
14Dec 10, 2018With version 13Download .zip
13Aug 2, 2016With version 9Download .zip
9Oct 28, 2015With version 6Download .zip
6Aug 13, 2012With version 5Download .zip
5Aug 1, 2012With version 4Download .zip
4May 9, 2012With version 3Download .zip
3Feb 17, 2012First versionDownload .zip

Read an SPL file

Open an SPL label file

Drop a Structured Product Labeling .xml file, or the .zip DailyMed downloads, to read it as a label. It is read in this browser tab and not uploaded.

Read in this browser tab; nothing is uploaded.

Versions and label text from DailyMed's SPL web services; a version's text is read from its SPL file, so it matches what DailyMed shows. Recent safety-related changes from FDA's Safety-related Labeling Changes database, which covers NDAs and CDER biologics, not generics. Lists refresh daily. DailyMed, National Library of Medicine

About label change history

How to read a comparison

Sections that changed come first, in the order a reviewer reads a label: boxed warning, recent major changes, indications, dosage, contraindications, warnings and precautions, adverse reactions, then the rest. Each shows the changed lines with one unchanged line either side; longer unchanged stretches are folded into a count. Table rows read left to right with cells separated by a bar.

The comparison covers the label text. Images, product data (NDC codes, ingredients, packaging) and formatting are not compared.

Which label is shown

A drug can have several labels: one per brand-name application (Ozempic, Wegovy and Rybelsus are three), and copies from repackagers. For each NDA or BLA the page takes the DailyMed set with the most versions, which is the application holder's. Generic labels are left out; they follow the brand's label.

Frequently asked questions

Where do the versions come from?
DailyMed, the National Library of Medicine's library of labels in Structured Product Labeling (SPL) format. Each time a company submits a revised label, DailyMed publishes it as a new version of the same set and keeps the old ones.
Is a new version a new FDA approval?
Not always. Companies also submit new versions for changes that need no FDA approval first, such as a new address, a new package size or a corrected typo. Safety changes FDA approved are listed in its Safety-related Labeling Changes database, linked below.
Why does the published date differ from the label's revised date?
The published date is when DailyMed posted the version. The label's own revised date, at the end of the highlights, is when the company revised the text, usually a few days to weeks earlier.
How is the comparison made?
Each section is matched by its standard LOINC code, then split into headings, paragraphs, list items and table rows. Lines are aligned with a longest-common-subsequence diff; a removed and an added line that share at least half their words are shown as one edited line with the changed words marked. Curly quotes, dash styles and spacing are ignored.
Is my SPL file uploaded?
No. A file you drop on this page is read in your browser tab and never sent to Arca.
Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.